Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 14.12
(-0.14%)
CNY 14.12
(-0.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.97 Billion CNY | 3.94% |
| 2022 | 16.33 Billion CNY | 26.59% |
| 2021 | 12.9 Billion CNY | 12.29% |
| 2020 | 11.49 Billion CNY | 26.72% |
| 2019 | 9.06 Billion CNY | 5.99% |
| 2018 | 8.55 Billion CNY | 8.49% |
| 2017 | 7.88 Billion CNY | 26.19% |
| 2016 | 6.25 Billion CNY | 9.52% |
| 2015 | 5.7 Billion CNY | 12.17% |
| 2014 | 5.08 Billion CNY | 9.23% |
| 2013 | 4.65 Billion CNY | 11.82% |
| 2012 | 4.16 Billion CNY | -1.41% |
| 2011 | 4.22 Billion CNY | 138.57% |
| 2010 | 1.77 Billion CNY | 17.34% |
| 2009 | 1.5 Billion CNY | 81.44% |
| 2008 | 831.91 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 16.61 Billion CNY | -1.99% |
| 2024 Q2 | 16.95 Billion CNY | -1.03% |
| 2024 Q1 | 17.12 Billion CNY | 0.88% |
| 2023 FY | 16.97 Billion CNY | 3.94% |
| 2023 Q2 | 18.15 Billion CNY | -0.51% |
| 2023 Q4 | 16.97 Billion CNY | -2.61% |
| 2023 Q3 | 17.43 Billion CNY | -3.96% |
| 2023 Q1 | 18.24 Billion CNY | 11.7% |
| 2022 Q3 | 14.92 Billion CNY | 3.76% |
| 2022 Q1 | 13.85 Billion CNY | 7.34% |
| 2022 Q4 | 16.33 Billion CNY | 9.46% |
| 2022 Q2 | 14.38 Billion CNY | 3.84% |
| 2022 FY | 16.33 Billion CNY | 26.59% |
| 2021 Q3 | 12.98 Billion CNY | -8.76% |
| 2021 FY | 12.9 Billion CNY | 12.29% |
| 2021 Q1 | 13.51 Billion CNY | 17.56% |
| 2021 Q2 | 14.23 Billion CNY | 5.34% |
| 2021 Q4 | 12.9 Billion CNY | -0.61% |
| 2020 FY | 11.49 Billion CNY | 26.72% |
| 2020 Q4 | 11.49 Billion CNY | 7.26% |
| 2020 Q1 | 9.82 Billion CNY | 8.34% |
| 2020 Q2 | 10.12 Billion CNY | 3.06% |
| 2020 Q3 | 10.71 Billion CNY | 5.8% |
| 2019 Q3 | 8.91 Billion CNY | 0.71% |
| 2019 Q1 | 8.81 Billion CNY | 3.05% |
| 2019 FY | 9.06 Billion CNY | 5.99% |
| 2019 Q4 | 9.06 Billion CNY | 1.78% |
| 2019 Q2 | 8.84 Billion CNY | 0.33% |
| 2018 FY | 8.55 Billion CNY | 8.49% |
| 2018 Q4 | 8.55 Billion CNY | 1.26% |
| 2018 Q3 | 8.45 Billion CNY | 1.67% |
| 2018 Q2 | 8.31 Billion CNY | 1.47% |
| 2018 Q1 | 8.19 Billion CNY | 3.85% |
| 2017 Q2 | 7.97 Billion CNY | 0.24% |
| 2017 Q1 | 7.95 Billion CNY | 27.27% |
| 2017 Q4 | 7.88 Billion CNY | 1.76% |
| 2017 FY | 7.88 Billion CNY | 26.19% |
| 2017 Q3 | 7.75 Billion CNY | -2.79% |
| 2016 Q2 | 6.04 Billion CNY | 3.44% |
| 2016 Q3 | 6.22 Billion CNY | 2.99% |
| 2016 Q4 | 6.25 Billion CNY | 0.33% |
| 2016 FY | 6.25 Billion CNY | 9.52% |
| 2016 Q1 | 5.84 Billion CNY | 2.46% |
| 2015 Q3 | 5.78 Billion CNY | 5.35% |
| 2015 FY | 5.7 Billion CNY | 12.17% |
| 2015 Q2 | 5.49 Billion CNY | 6.24% |
| 2015 Q1 | 5.17 Billion CNY | 1.67% |
| 2015 Q4 | 5.7 Billion CNY | -1.43% |
| 2014 Q3 | 5.02 Billion CNY | 0.66% |
| 2014 FY | 5.08 Billion CNY | 9.23% |
| 2014 Q4 | 5.08 Billion CNY | 1.34% |
| 2014 Q2 | 4.98 Billion CNY | 3.45% |
| 2014 Q1 | 4.82 Billion CNY | 3.51% |
| 2013 Q4 | 4.65 Billion CNY | -1.09% |
| 2013 FY | 4.65 Billion CNY | 11.82% |
| 2013 Q1 | 4.32 Billion CNY | 3.81% |
| 2013 Q2 | 4.56 Billion CNY | 5.68% |
| 2013 Q3 | 4.7 Billion CNY | 3.06% |
| 2012 Q4 | 4.16 Billion CNY | -3.58% |
| 2012 Q1 | 4.27 Billion CNY | 1.13% |
| 2012 Q2 | 4.24 Billion CNY | -0.76% |
| 2012 Q3 | 4.32 Billion CNY | 1.88% |
| 2012 FY | 4.16 Billion CNY | -1.41% |
| 2011 FY | 4.22 Billion CNY | 138.57% |
| 2011 Q2 | 1.89 Billion CNY | 0.0% |
| 2011 Q3 | 4.16 Billion CNY | 119.87% |
| 2011 Q4 | 4.22 Billion CNY | 1.53% |
| 2010 Q4 | 1.77 Billion CNY | 0.0% |
| 2010 FY | 1.77 Billion CNY | 17.34% |
| 2009 FY | 1.5 Billion CNY | 81.44% |
| 2008 FY | 831.91 Million CNY | 0.0% |